LINC01890

Across TCGA pan-cancer cohorts, LINC01890 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01890’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC01890 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01890 is over-expressed in tumor, although a few such as BRCA and LUAD show the opposite, repressed pattern.

BRCA, KIRC, and LUAD are the cancer types where LINC01890 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01890 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.024	.001	6	view →
KIRC	All	All	+0.026	<.001	5	view →
LUAD	All	All	−0.045	.009	4	view →
PAAD	All	All	−0.072	.032	2	view →
LUSC	Male	All	−0.049	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01890–BRCA

Open the BRCA breakdown →